McKesson signs agreement to acquire Precision Medicine Group
McKesson acquires the firm for $2.25 billion to enhance clinical research and biopharma commercialization services within its Oncology segment.
See the latest news and media coverage for McKesson. We track all announcements, press releases, and industry mentions in real time, all in one place.
Diversified healthcare services and distribution company
mckesson.comLast updated
In short: McKesson raised its fiscal 2027 guidance and signed a $2.25 billion deal for Precision Medicine Group to expand its oncology business.
McKesson acquires the firm for $2.25 billion to enhance clinical research and biopharma commercialization services within its Oncology segment.
The board declared a regular dividend payable October 1, 2026, to shareholders of record on September 1, 2026.
It highlights key milestones across people, partners, community, and planet pillars, including digital learning, oncology support, and climate initiatives.
The new 330,000-square-foot distribution center will expand capacity and strengthen supply chain resilience.
McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-...
McKesson ( ) has provided an update. McKesson Corporation reported that on August 25, 2026, it discovered a cybersecurity incident affecting its information systems, and...
U.S. drug distributor McKesson said on Tuesday it would buy privately held Precision Medicine Group...
McKesson agreed to acquire Precision Medicine Group to expand its oncology portfolio.The company raised its quarterly ...
Track McKesson and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to McKesson and other trending companies.